WVU Medicine Introduces Osseointegrated Prosthesis Technology

WVU Medicine is one of the first medical centers in the country to offer the Integrum Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA™) Implant System for the treatment of lower extremity amputations.

“Being one of the select facilities in the country to offer a multidisciplinary amputation clinic that incorporates this groundbreaking technology of osseointegration places our group at the forefront of amputee care,” Brock Lindsey, M.D., WVU Medicine orthopedic surgeon and Musculoskeletal Oncology and Adult Reconstruction director, said.

Osseointegration is a surgical procedure in which the prosthesis is integrated and permanently implanted into the bone. The revolutionary approach and viable alternative to a standard socket prosthesis offers a range of benefits for amputee patients, including improved mobility, enhanced comfort, reduced pressure, and stable attachment.

The OPRA™ Implant System is installed via two surgical procedures. In the first surgery, the fixture is implanted into the bone, which requires about six months of healing time for the bone to fully grow onto the fixture and anchor it. In the second surgery, an abutment is attached to the fixture and extends through the skin to connect to the external prosthesis. Another six months of rehabilitation is required, including fitting with a customized final prosthesis.

“We have already seen an increase in function and ease of use in our patients who have had the procedure,” Dr. Lindsey said.

The OPRA™ Implant System is the first and only FDA-approved technology for bone-anchored prostheses in the United States. In December 2020, the FDA approved OPRA for individuals who have transfemoral, or above-knee, amputations and those who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.

For an appointment in the amputation clinic, call 304-598-4830. For more information on WVU Medicine Orthopedics, visit WVUMedicine.org/Ortho.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.
The rehabilitation robotic glove is a training device that combines EMG electromyographic feedback and flexible robotics for patients with stroke or hand disabilities to train and repair dexterity.

By using this website you agree to accept Medical Device News Magazine Privacy Policy